Investor relations


The purpose of Gradientech’s Investor Relations is to continuously inform the capital market about the company’s operations and development. Here you will find press releases and financial reports as well as information about the share and corporate governance. You can also receive all our press releases to your email as soon as we post them. Just click the button below and fill in your email in the form and approve the confirmation email sent back to you. It is just as easy to unsubscribe whenever you want. Welcome!

Keep up to date - subscribe

Annual report 2023

Here you can read about significant events during the year, our target market and the strategy going forward.

To the annual report


AGM 2024

The 2024 annual general meeting took place on Tuesday, 7 May 2024. Here you can find information from the general meeting. Here you can also find all the documentation from previous general meetings.

To general meetings

Redeye Life Science Day

Sara Thorslund (CEO), presented Gradientech and the QuickMIC System at the investor event Redeye Life Science Day on 23 November 2023.

Watch presentation

About Gradientech

Gradientech is leading the field of ultra-rapid antibiotic susceptibility testing. We develop next-generation diagnostics that provide patients with the right dose of the right medicine at the right time.

Read more